CannaPhytica BioMed (CannaPhytica) is a Cannabis focused biotechnology company with 5 years of unique provenance in the cannabis industry and extensive ties with the lucrative German and European markets. CannaPhytica was formed to bring several income streams under one roof –research and development, product development, import – export and wholesale distribution into the German market.

CannaPhytica is building on many years of experience in the medicinal cannabis and pharmaceutical sectors, becoming one of the fastest growing opportunities in the global healthcare sector.

With a foothold and headquarters in Berlin as well as a R&D centre focusing exclusively on THC in Sanitz, Rostock additionally a recently new Warehouse/ Secure Bunker/ Distribution in Berlin, CannaPhytica is well established on imminent opportunities in utilising cutting edge technology to implement full integration and control over the chain of supply to the pharmaceutical industry.

Established in 2017, Cannaphytica is the holder of an EU-GDP license and is therefore approved to supply generic pharmaceuticals in finished dosage forms (FDFs), including active pharmaceutical ingredients (APIs) and other healthcare products. Along with the manufacturing of pharmaceuticals, the company also specializes in trading pharmaceuticals and medical care products.